Clinical Evaluation of ErbB-Targeted CAR T-Cells, Following Intracavity Delivery in Patients with ErbB-Expressing Solid Tumors

Methods in molecular biology (Clifton, N.J.)

Volumn 1317, Issue , 2015, Pages 365-382

  Papa, Sophie ^a   van Schalkwyk, May ^b   Maher, John ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ADVERSE EFFECTS; BIOASSAY; FEMALE; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; INTRALESIONAL DRUG ADMINISTRATION; MESOTHELIOMA; METABOLISM; NEOPLASMS; OVARIAN NEOPLASMS; PLEURAL NEOPLASMS; RANDOMIZED CONTROLLED TRIAL (TOPIC); T LYMPHOCYTE;

ENDPOINT DETERMINATION; ERBB RECEPTORS; FEMALE; HUMANS; IMMUNOTHERAPY; INJECTIONS, INTRALESIONAL; MESOTHELIOMA; NEOPLASMS; OVARIAN NEOPLASMS; PLEURAL NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 85026255825     PISSN: None     EISSN: 19406029     Source Type: Journal    
DOI: 10.1007/978-1-4939-2727-2_21     Document Type: Article

References (0)